HR 1384 United States House · 117th Congress

Mainstreaming Addiction Treatment Act of 2021

Summary

Mainstreaming Addiction Treatment Act of 2021 This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment). Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity. The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.

Bill status in committee 1 of 4 stages cleared

Introduction

Feb 2021

Committee Review

Floor Vote

President

Introduced Feb 25, 2021 Last action Apr 28, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 28, 2021

Committee

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

lower

Feb 26, 2021

Committee

Referred to the Subcommittee on Health.

lower

Feb 25, 2021

Committee

Referred to the Subcommittee on Health.

lower

Feb 25, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Feb 25, 2021

Introduced

Introduced in House

lower

1 primary · 250 co-sponsors